Congress worried about health IT regulations; New application for ultrasound systems being developed;

@FierceMedDev: Singapore team designs nanotech glaucoma treatment for sustained release. Story from FierceDrugDelivery | Follow @FierceMedDev

@VarunSaxena2: The EU continues to talk medical device reform. What will the finished regulations look like? More from The National Law Review | Follow @VarunSaxena2

@MichaelGFierce: 'Quadrapeutics' method delivers chemo, nanogold, infrared light and radiation to kill cancer. More from FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: Learning a second language could help ward off dementia, say researchers @UniofEdinburgh. More | Follow @EmilyWFierce

> Members of Congress wrote a letter to the Office of the National Coordinator for Health Information Technology saying its proposal to regulate health IT goes beyond what is allowed under the law. Story

> The European Union is discussing new medical device regulations. Story

> Researchers have developed an ultrasound system that can move objects and has applications for drug delivery. Story

Biotech News

@FierceBiotech: Trending--Sanofi CEO Viehbacher now calls beloved Boston biotech hub his home. More | Follow @FierceBiotech

@JohnCFierce: No. 1 - $31M; No. 2 - $8M: 2013's 10 best-compensated R&D chiefs in biopharma. Report | Follow @JohnCFierce

@DamianFierce: Science pays: 2013's 10 best-compensated R&D chiefs in biopharma. Feature | Follow @DamianFierce

@EmilyMFierce: Genetically engineered malaria parasite could expedite vaccine development. ICYMI from FierceBiotech Research | Follow @EmilyMFierce

> Biotech boom or no, many startups are staying virtual. Story

> Analyst prods Amgen to join the Big Pharma breakup party. More

> Biotech claims a dubious Alzheimer's 'breakthrough.' Item

> Trevi, Complexa bag $38M in VC cash to hit the gas on R&D. Article

> Shire sweetens its arGEN-X deal with a $20M investment. News

Pharma News

@FiercePharma: Catch this week's issue of FiercePharmaMarketing here. Issue | Follow @FiercePharma

@TracyStaton: Novartis nabs Merck exec Bruno Strigini to head up oncology business. More | Follow @TracyStaton

@EricPFierce: RT from @FiercePharma: Smells like team spirit: AstraZeneca CEO says Pfizer fight has it pumped to perform. Story | Follow @EricPFierce

@CarlyHFierce: Out with the old, in with the new: Merck, GSK, others put established drugs on the block. News | Follow @CarlyHFierce

@JustinHFierce: #NPPCWPX THE WORLD PORK EXPO HAS A MEDIA ROOM. | Follow @JustinHFierce

> Where has all the Big Pharma marketing money gone? Emerging markets. More

> Medicare opens door wide for Gilead's $84K hep C drug Sovaldi. Story

> Persevering in Eastern Europe despite unrest, Stada eyes more deals. News

Drug Delivery News

> 'Quadrapeutics' method delivers chemo, nanogold, infrared light and radiation to kill cancer. More

> Singapore team designs nanotech glaucoma treatment for sustained release. Article

> First cheek-bound film for opioid dependence nears PDUFA date. Report

> Investors watch RNA therapy companies for signs of future profits. Item

> FDA approves first nasally delivered gel for 'Low T.' Story

Diagnostics News

> Quest and Memorial Sloan-Kettering team for next-generation gene sequencing. Report

> Five urine biomarkers may offer a new way to spot male infertility. Item

> Provista broadens ASU cancer biomarker licensing deal. More

> NanoString to produce companion test for Celgene's blockbuster cancer drug Revlimid. Article

> Almac at ASCO: Dx spots ovarian cancer patients for whom Roche's Avastin would hurt. Story

Pharma Marketing News

> Pfizer launches next new Lipitor copay program, Medicare and ACA included. Report

> GlaxoSmithKline's Chinese reps demand to be repaid for bribes, FT reports. More

> Novartis, Merck KGaA use digital tracking in MS patients to up their competitive game. Story

> AstraZeneca's Crestor gets a boost from Cigna data-crunching deal. Article

> Pfizer launches next new Lipitor copay program, Medicare and ACA included. More

Suggested Articles

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.